METTL3 and hepatocellular carcinoma: Multivariate analyses revealed that Mettl3 expression levels, with a hazard ratio (HR) of 3.3405 and a 95% CI of 1.652-7.019, were independent prognostic factors in patients with HCC (Table 1).